Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008450HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS10034714HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS20027526HPVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44009999HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44012786HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44033742HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44000630HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TCGA Plot Options
Drug Information
GeneCHRNA7
DrugBank IDDB11726
Drug NameEncenicline
Target IDBE0002341
UniProt IDP36544
Regulation Typepartial agonist
PubMed IDs25438724
CitationsBarbier AJ, Hilhorst M, Van Vliet A, Snyder P, Palfreyman MG, Gawryl M, Dgetluck N, Massaro M, Tiessen R, Timmerman W, Hilt DC: Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective alpha7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies. Clin Ther. 2015 Feb 1;37(2):311-24. doi: 10.1016/j.clinthera.2014.09.013. Epub 2014 Oct 14.
GroupsInvestigational
Direct Classification1-benzothiophenes
SMILESClC1=C2SC(=CC2=CC=C1)C(=O)N[C@H]1CN2CCC1CC2
Pathways
PharmGKB
ChEMBLCHEMBL2151572